Oh dear, oh dear oh dear oh dear:
The National Institute for Clinical Excellence (Nice) has the difficult task of deciding which treatments from an increasingly expensive menu should be available on the NHS. To make the right choices, it needs access to all available data. And yet a report last week revealed that some antidepressants, taken by around four million people in Britain, work no better than placebos in mild cases of the illness.
Nice had been unaware of the fact because the data had never before been published. Most research is conducted by drug companies and Nice has no authority to compel them to reveal their findings. If a study casts doubt on a drug\’s benefits, it can be buried.
You should try reading your sister paper, my little bubberoonies. From yesterday:
In fact the new study added nothing (and it was ridiculously badly reported): we already knew that antidepressants perform only marginally better than placebo, and the National Institute for Health and Clinical Excellence (Nice) guidelines has actively advised against using them in milder depression since 2004.
Why do they bother, eh?